GDF15 Deficiency Promotes High Fat Diet-induced Obesity in Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Aug 3

PMID 30070999

Citations 46

Authors

Thanhvien Tran

Jingping Yang

Jonitha Gardner

Yumei Xiong

Affiliations

Soon will be listed here.

Abstract

Pharmacological treatment of recombinant growth differentiation factor 15 (GDF15) proteins reduces body weight in obese rodents and primates. Paradoxically, circulating GDF15 levels are increased in obesity. To investigate the role of endogenous GDF15 in obesity development, we put GDF15 knockout mice and wildtype controls on high fat diet for the mice to develop diet-induced obesity. Compared to wildtype animals, GDF15 knockout mice were more prone to high fat diet-induced obesity. Male knockout mice showed worse glucose tolerance, lower locomotor activity and lower metabolic rate than wildtype mice. Additionally, GDF15 deficiency increased occurrences of high fat diet-induced skin lesions. Our data suggests that endogenous GDF15 has a protective role in obesity development and lack of GDF15 aggravates the progression of obesity and associated pathological conditions. Elevated GDF15 levels in obesity may have resulted from a response to overcome GDF15 resistance.

Citing Articles

Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling.

Feetham C, Collabolletta V, Worth A, Shoop R, Groom S, Harding C Nat Commun. 2024; 15(1):10749.

PMID: 39737892 PMC: 11685588. DOI: 10.1038/s41467-024-54367-y.

Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges.

Zhang J, Sun J, Li J, Xia H J Cell Mol Med. 2024; 28(24):e70251.

PMID: 39700016 PMC: 11657595. DOI: 10.1111/jcmm.70251.

GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature.

Igual-Gil C, Bishop C, Jahnert M, Johann K, Coleman V, Baum V Sci Rep. 2024; 14(1):26989.

PMID: 39505926 PMC: 11541726. DOI: 10.1038/s41598-024-77448-w.

GDF15 associates with, but is not responsible for, exercise-induced increases in corticosterone and indices of lipid utilization in mice.

Arbeau M, Baranowski B, Jeromson S, Bellucci A, Akcan M, Trang S J Appl Physiol (1985). 2024; 137(6):1512-1523.

PMID: 39480267 PMC: 11687845. DOI: 10.1152/japplphysiol.00519.2024.

GDF15 Knockout Does Not Substantially Impact Perinatal Body Weight or Neonatal Outcomes in Mice.

Mulcahy M, El Habbal N, Redd J, Sun H, Gregg B, Bridges D Endocrinology. 2024; 165(12).

PMID: 39445824 PMC: 11577612. DOI: 10.1210/endocr/bqae143.

References

Macia L, Tsai V, Nguyen A, Johnen H, Kuffner T, Shi Y . Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One. 2012; 7(4):e34868. PMC: 3325923. DOI: 10.1371/journal.pone.0034868. View

Ebbeling C, Swain J, Feldman H, Wong W, Hachey D, Garcia-Lago E . Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012; 307(24):2627-34. PMC: 3564212. DOI: 10.1001/jama.2012.6607. View

Yang L, Chang C, Sun Z, Madsen D, Zhu H, Padkjaer S . GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017; 23(10):1158-1166. DOI: 10.1038/nm.4394. View

Burkholder T, Foltz C, Karlsson E, Linton C, Smith J . Health Evaluation of Experimental Laboratory Mice. Curr Protoc Mouse Biol. 2012; 2:145-165. PMC: 3399545. DOI: 10.1002/9780470942390.mo110217. View

Musallam K, Taher A, Duca L, Cesaretti C, Halawi R, Cappellini M . Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia. Blood Cells Mol Dis. 2011; 47(4):232-4. DOI: 10.1016/j.bcmd.2011.07.005. View

Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J . The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res. 2006; 98(3):351-60. DOI: 10.1161/01.RES.0000202805.73038.48. View

Emmerson P, Wang F, Du Y, Liu Q, Pickard R, Gonciarz M . The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017; 23(10):1215-1219. DOI: 10.1038/nm.4393. View

Tsai V, Zhang H, Manandhar R, Lee-Ng K, Lebhar H, Marquis C . Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity. Int J Obes (Lond). 2017; 42(3):561-571. DOI: 10.1038/ijo.2017.258. View

Fernandez-Fernandez R, Martini A, Navarro V, Castellano J, Dieguez C, Aguilar E . Novel signals for the integration of energy balance and reproduction. Mol Cell Endocrinol. 2006; 254-255:127-32. DOI: 10.1016/j.mce.2006.04.026. View

10.

Hariri N, Thibault L . High-fat diet-induced obesity in animal models. Nutr Res Rev. 2010; 23(2):270-99. DOI: 10.1017/S0954422410000168. View

11.

Scheinfeld N . Obesity and dermatology. Clin Dermatol. 2004; 22(4):303-9. DOI: 10.1016/j.clindermatol.2004.01.001. View

12.

Brown D, Hance K, Rogers C, Sansbury L, Albert P, Murphy G . Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?. Cancer Epidemiol Biomarkers Prev. 2011; 21(2):337-46. PMC: 7238292. DOI: 10.1158/1055-9965.EPI-11-0786. View

13.

Kim J, Kosak J, Kim J, Kissling G, Germolec D, Zeldin D . NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response. Mediators Inflamm. 2013; 2013:641851. PMC: 3662179. DOI: 10.1155/2013/641851. View

14.

Ellacott K, Morton G, Woods S, Tso P, Schwartz M . Assessment of feeding behavior in laboratory mice. Cell Metab. 2010; 12(1):10-7. PMC: 2916675. DOI: 10.1016/j.cmet.2010.06.001. View

15.

Hsu J, Crawley S, Chen M, Ayupova D, Lindhout D, Higbee J . Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017; 550(7675):255-259. DOI: 10.1038/nature24042. View

16.

Xiong Y, Walker K, Min X, Hale C, Tran T, Komorowski R . Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys. Sci Transl Med. 2017; 9(412). DOI: 10.1126/scitranslmed.aan8732. View

17.

Chrysovergis K, Wang X, Kosak J, Lee S, Kim J, Foley J . NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J Obes (Lond). 2014; 38(12):1555-64. PMC: 4135041. DOI: 10.1038/ijo.2014.27. View

18.

Yosipovitch G, DeVore A, Dawn A . Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007; 56(6):901-16. DOI: 10.1016/j.jaad.2006.12.004. View

19.

Zhang Y, Li Q, Rao E, Sun Y, Grossmann M, Morris R . Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet. Immunity. 2015; 42(5):953-964. PMC: 4440244. DOI: 10.1016/j.immuni.2015.04.016. View

20.

Hill J, Melanson E, WYATT H . Dietary fat intake and regulation of energy balance: implications for obesity. J Nutr. 2000; 130(2S Suppl):284S-288S. View